{"schema_version":"secwatch.filing_event.v1","accession":"0001860742-24-000003","form_type":"8-K","ticker":"BLCO","cik":"0001860742","company_name":"Bausch & Lomb Corp","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.121875+00:00","generated_at":"2026-06-05T22:21:37.523934+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bausch + Lomb Q4 rev $1.17B (+18% YoY); guides FY 2024 rev $4.6-4.7B","bullets":["Q4 2023 revenue $1.173B (+18% YoY); full-year revenue $4.146B (+10% YoY).","GAAP net loss attributable to BLCO: Q4 $54M, FY $260M; prior year Q4 loss $1M, FY income $6M.","Adjusted EBITDA Q4 $231M (+$50M YoY); FY $738M (+$18M YoY). 2024 guidance: $840-$890M.","Pharmaceuticals segment revenue up 67% in Q4 driven by XIIDRA acquisition and MIEBO launch.","Cash flow from operations negative $17M for FY 2023 vs +$345M in 2022 due to inventory build and timing."],"urls":{"canonical":"https://secwatch.observer/filing/0001860742-24-000003","json":"https://secwatch.observer/filing/0001860742-24-000003.json","markdown":"https://secwatch.observer/filing/0001860742-24-000003.md","text":"https://secwatch.observer/filing/0001860742-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860742/000186074224000003/0001860742-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860742/000186074224000003/blco-20240221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T22:21:37.523934+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"176319b2c3092f0a499c03b3ee609083ef046455","claim":"Bausch & Lomb Corp reported financial results for the quarter and the year ended December 31, 2023.","evidence_excerpt":"On February 21, 2024, Bausch + Lomb Corporation (the “Company”) issued a press release announcing results of operations for the quarter and the year ended December 31, 2023 and certain other financial information as of and for the quarter and the year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074224000003/0001860742-24-000003-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and the year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}